Interleukin-10 as a Regulatory Cytokine Induced by Cellular Stress: Molecular Aspects

References

• Fiorentino D. F., Bond M. W., Mosmann T. R. Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J. Exp. Med. 1989; 170: 2081–2095
   PubMed Web of Science ®Google Scholar
• Moore K. W., Vieira P., Fiorentino D. F., Trounstine M. L., Khan T. A., Mosmann T. R. Homology of cytokine synthesis inhibitory factor (IL-10) to the Epstein-Barr virus gene BCRFI. Science 1990; 248: 1230–1234
   PubMed Web of Science ®Google Scholar
• Vieira P., de Waal Malefyt R., Dang M. N., Johnson K. E., Kastelein R., Fiorentino D. F., Devries J. E., Roncarolo M. G., Mosmann T. R., Moore K. W. Isolation and expression of human cytokine synthesis inhibitory factor cDNA clones: homology to Epstein-Barr virus open reading frame BCRFI. Proc. Natl. Acad. Sci. USA 1991; 88: 1172–1176
   PubMed Web of Science ®Google Scholar
• Windsor W. T., Syto R., Tsarbopoulos A., Zhang R. M., Durkin J., Baldwin S., Paliwal S., Mui P. W., Pramanik B., Trotta P. P., et al. Disulfide bond assignments and secondary structure analysis of human and murine interleukin-10. Biochemistry 1993; 32: 8807–8815
   PubMedGoogle Scholar
• Kim J. M., Brannan C. I., Copeland N. G., Jenkins N. A., Khan T. A., Moore K. W. Structure of the mouse IL-10 gene and chromosomal localization of the mouse and human genes. J. Immunol. 1992; 148: 3618–3623
   PubMed Web of Science ®Google Scholar
• Yssel H., Malefyt R. D., Roncarolo M. G., Abrams J. S., Lahesmaa R., Spits H., Devries J. E. IL-10 is produced by subsets of human CD4+ T-cell clones and peripheral blood T cells. J. Immunol. 1992; 149: 2378–2384
   PubMed Web of Science ®Google Scholar
• Delprete G., Decarli M., Almerigogna F., Giudizi M. G., Biagiotti R., Romagnani S. Human IL-10 is produced by both type-1 helper (Th1) and type-2 helper (Th2) T-cell clones and inhibits their antigen-specific proliferation and cytokine production. J. Immunol. 1993; 150: 353–360
   PubMed Web of Science ®Google Scholar
• Sad S., Marcotte R., Mosmann T. R. Cytokine-induced differentiation of precursor mouse CD8+ T cells into cytotoxic CD8+ T cells secreting Th1 or Th2 cytokines. Immunity 1995; 2: 271–279
   PubMed Web of Science ®Google Scholar
• Dewaalmalefyt R., Abrams J., Bennett B., Figdor C. G., Devries J. E. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J. Exp. Med. 1991; 174: 1209–1220
   PubMedGoogle Scholar
• Fiorentino D. F., Zlotnik A., Mosmann T. R., Howard M., Ogarra A. IL-10 inhibits cytokine production by activated macrophages. J. Immunol. 1991; 147: 3815–3822
   PubMed Web of Science ®Google Scholar
• O'Garra A., Stapleton G., Dhar V., Pearce M., Schumacher J., Rugo H., Barbis D., Stall A., Cupp J., Moore K., et al. Production of cytokines by mouse B cells: B lymphomas and normal B cells produce interleukin 10. Int. Immunol. 1990; 2: 821–832
   PubMed Web of Science ®Google Scholar
• Benjamin D., Knobloch T. J., Dayton M. A. Human B-cell interleukin-10 — B-cell lines derived from patients with acquired immunodeficiency syndrome and Burkitts lymphoma constitutively secrete large quantities of interleukin-10. Blood 1992; 80: 1289–1298
   PubMed Web of Science ®Google Scholar
• Burdin N., Peronne C., Banchereau J., Rousset F. Epstein-Barr virus Transformation induces lymphocytes-B to produce human interleukin-10. J. Exp. Med. 1993; 177: 295–304
   PubMed Web of Science ®Google Scholar
• Nakajima H., Gleich G. J., Kita H. Constitutive production of IL-4 and IL-10 and stimulated production of IL-8 by normal peripheral blood eosinophils. J. Immunol. 1996; 156: 4859–4866
   PubMedGoogle Scholar
• Enk A. H., Katz S. I. Identification and induction of keratinocyte-derived IL-10. J. Immunol. 1992; 149: 92–95
   PubMed Web of Science ®Google Scholar
• Fouqueray B., Boutard V., Philippe C., Kornreich A., Marchant A., Perez J., Goldman M., Baud L. Mesangial cell-derived interleukin-10 modulates mesangial cell response to lipopolysaccharide. Am. J. Pathol. 1995; 147: 176–182
   PubMed Web of Science ®Google Scholar
• Alfrey E. J., Most D., Wang X. G., Lee L. K., Holm B., Krieger N. R., Sibley R. K., Huie P., Dafoe D. C. Interferon-gamma and interleukin-10 messenger RNA are up-regulated after orthotopic liver transplantation in tolerant rats: Evidence for cytokine-mediated immune dysregulation. Surgery 1995; 118: 399–405
   PubMedGoogle Scholar
• Williams K., Dooley N., Uivestad E., Becher B., Antel J. P. IL-10 production by adult human derived microglial cells. Neurochem. Int. 1996; 29: 55–64
   PubMedGoogle Scholar
• Mizuno T., Sawada M., Marunouchi T., Suzumura A. Production of interleukin-10 by mouse glial cells in culture. Biochem. Biophys. Res. Commun. 1994; 205: 1907–1915
   PubMed Web of Science ®Google Scholar
• Marietta E. V., Chen Y. Y., Weis J. H. Modulation of expression of the antiinflammatory cytokines interleukin-13 and interleukin-10 by interleukin-3. Eur. J. Immunol. 1996; 26: 49–56
   PubMedGoogle Scholar
• Rady P. L., Smith E. M., Cadet P., Opp M. R., Tyring S. K., Hughes T. K. Presence of interleukin-10 transcripts in human pituitary and hypothalamus. Cell Mol. Neurobiol. 1995; 15: 289–296
   PubMedGoogle Scholar
• Bonfield T. L., Konstan M. W., Burfeind P., Panuska J. R., Hilliard J. B., Berger M. Normal bronchial epithelial cells constitutively produce the anti-inflammatory cytokine interleukin-10, which is downregulated in cystic fibrosis. Amer. J. Respir. Cell Molec. Biol. 1995; 13: 257–261
   PubMedGoogle Scholar
• Pisa P., Halapi E., Pisa E. K., Gerdin E., Hising C., Bucht A., Gerdin B., Kiessling R. Selective expression of interleukin-10, interferon-gamma, and granulocyte macrophage colony-stimulating factor in ovarian cancer biopsies. Proc. Natl. Acad. Sci. USA 1992; 89: 7708–7712
   PubMed Web of Science ®Google Scholar
• Gotlieb W. H., Abrams J. S., Watson J. M., Velu T. J., Berek J. S., Martinezmaza O. Presence of interleukin 10 (IL-10) in the ascites of patients with ovarian and other intra-abdominal cancers. Cytokine 1992; 4: 385–390
   PubMed Web of Science ®Google Scholar
• Yamamura M., Modlin R. L., Ohmen J. D., Moy R. L. Local expression of antiinflammatory cytokines in cancer. J. Clin. Invest. 1993; 91: 1005–1010
   PubMed Web of Science ®Google Scholar
• Chen Q. Y., Daniel V., Maher D. W., Hersey P. Production of IL-10 by melanoma cells — examination of its role in immunosuppression mediated by melanoma. Int. J. Cancer 1994; 56: 755–760
   PubMed Web of Science ®Google Scholar
• Stewart J. P., Behm F. G., Arrand J. R., Rooney C. M. Differential expression of viral and human interleukin-10 (IL-10) by primary B cell tumors and B cell Lines. Virology 1994; 200: 724–732
   PubMedGoogle Scholar
• Nakagomi H., Pisa P., Pisa E. K., Yamamoto Y., Halapi E., Backlin K., Juhlin C., Kiessling R. Lack of interleukin-2 (IL-2) expression and selective expression of IL-10 mRNA in human renal cell carcinoma. Int. J. Cancer 1995; 63: 366–371
   PubMed Web of Science ®Google Scholar
• Kuhn R., Lohler J., Rennick D., Rajewsky K., Muller W. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 1993; 75: 263–274
   PubMed Web of Science ®Google Scholar
• Marchant A., Bruyns C., Vandenabeele P., Ducarme M., Gerard C., Delvaux A., Degroote D., Abramowicz D., Velu T., Goldman M. Interleukin-10 controls interferon-gamma and tumor necrosis factor production during experimental endotoxemia. Eur. J. Immunol. 1994; 24: 1167–1171
   PubMedGoogle Scholar
• Florquin S., Amraoui Z., Abramowicz D., Goldman M. Systemic release and protective role of IL-10 in staphylococcal enterotoxin B-induced shock in mice. J. Immunol. 1994; 153: 2618–2623
   Google Scholar
• Moore K. W., Ogarra A., Malefyt R. D., Vieira P., Mosmann T. R. Interleukin-10. Annu. Rev. Immunol. 1993; 11: 165–190
   PubMed Web of Science ®Google Scholar
• Bogdan C., Vodovotz Y., Nathan C. Macrophage deactivation by interleukin-10. J. Exp. Med. 1991; 174: 1549–1555
   PubMed Web of Science ®Google Scholar
• Cassatella M. A., Meda L., Bonora S., Ceska M., Constantin G. Interleukin-10 (IL-10) inhibits the release of proinflammatory cytokines from human polymorphonuclear leukocytes — evidence for an autocrine role of tumor necrosis factor and IL-1 beta in mediating the production of IL-8 triggered by lipopolysaccharide. J. Exp. Med. 1993; 178: 2207–2211
   PubMed Web of Science ®Google Scholar
• Takanaski S., Nonaka R., Xing Z., Obyrne P., Dolovich J., Jordana M. Interleukin 10 inhibits lipopolysaccharide-induced survival and cytokine production by human peripheral blood eosinophils. J. Exp. Med. 1994; 180: 711–715
   PubMed Web of Science ®Google Scholar
• Arock M., Zuanyamorim C., Singer M., Benhamou M., Pretolani M. Interleukin-10 inhibits cytokine generation from mast cells. Eur. J. Immunol. 1996; 26: 166–170
   PubMed Web of Science ®Google Scholar
• Gazzinelli R. T., Oswald I. P., James S. L., Sher A. IL-10 Inhibits parasite killing and nitrogen oxide production by IFN-gamma-activated macrophages. J. Immunol. 1992; 148: 1792–1796
   PubMed Web of Science ®Google Scholar
• Cunha F. Q., Moncada S., Liew F. Y. Interleukin-10 (IL-10) Inhibits the induction of nitric oxide synthase by interferon-gamma in murine macrophages. Biochem. Biophys. Res. Commun. 1992; 182: 1155–1159
   PubMed Web of Science ®Google Scholar
• Niiro H., Otsuka T., Kuga S., Nemoto Y., Abe M., Hara N., Nakano T., Ogo T., Niho Y. IL-10 inhibits prostaglandin E(2) production by lipopolysac-charide-stimulated monocytes. Int. Immunol. 1994; 6: 661–664
   PubMed Web of Science ®Google Scholar
• Pradier O., Gerard C., Delvaux A., Lybin M., Abramowicz D., Capel P., Velu T., Goldman M. Interleukin-10 inhibits the induction of monocyte procoagulant activity by bacterial lipopolysaccharide. Eur. J. Immunol. 1993; 23: 2700–2703
   PubMedGoogle Scholar
• Jenkins J. K., Malyak M., Arend W. P. The effects of interleukin-10 on interleukin-receptor antagonist and interleukin-1-beta production in human monocytes and neutrophils. Lymphokine. Cytokine. Res. 1994; 13: 84–89
   Google Scholar
• Cassatella M. A., Meda L., Gasperini S., Calzetti F., Bonora S. Interleukin 10 (IL-10) upregulates IL-1 receptor antagonist production from lipopolysaccharide-stimulated human polymorphonuclear leukocytes by delaying mRNA degradation. J. Exp. Med. 1994; 179: 1695–1699
   PubMed Web of Science ®Google Scholar
• de Waal Malefyt R., Haanen J., Spits H., Roncarolo M. G., Tevelde A., Figdor C., Johnson K., Kastelein R., Yssel H., Devries J. E. Interleukin-10 (IL-10) and viral-IL-10 strongly reduce antigen-specific human T-cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class-II major histocompability complex expression. J. Exp. Med. 1991; 174: 915–924
   PubMed Web of Science ®Google Scholar
• Ding L., Linsley P. S., Huang L. Y., Germain R. N., Shevach E. M. IL-10 inhibits macrophage costimulatory activity by selectively inhibiting the up-regulation of B7 expression. J. Immunol. 1993; 151: 1224–1234
   PubMed Web of Science ®Google Scholar
• Willems F., Marchant A., Delville J. P., Gerard C., Delvaux A., Velu T., Deboer M., Goldman M. Interleukin-10 inhibits B7 and intercellular adhesion molecule-1 expression on human monocytes. Eur. J. Immunol. 1994; 24: 1007–1009
   PubMed Web of Science ®Google Scholar
• Dandrea A., Asteamezaga M., Valiante N. M., Ma X. J., Kubin M., Trinchieri G. Interleukin-10 (IL-10) inhibits human lymphocyte interferon gamma-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells. J. Exp. Med. 1993; 178: 1041–1048
   PubMedGoogle Scholar
• Macatonia S. E., Doherty T. M., Knight S. C., Ogarra A. Differential Effect of IL-10 on dendritic cell-induced T-cell proliferation and IFN-gamma production. J. Immunol. 1993; 150: 3755–3764
   PubMedGoogle Scholar
• Caux C., Massacrier C., Vanbervliet B., Barthelemy C., Liu Y. J., Banchereau J. Interleukin 10 inhibits T cell alloreaction induced by human dendritic cells. Int. Immunol. 1994; 6: 1177–1185
   PubMed Web of Science ®Google Scholar
• Enk A. H., Angeloni V. L., Udey M. C., Katz S. I. Inhibition of Langerhans cell antigen-presenting function by IL-10 — a role for IL-10 in induction of tolerance. J. Immunol. 1993; 151: 2390–2398
   PubMed Web of Science ®Google Scholar
• Buelens C., Willems F., Delvaux A., Pierard G., Delville J. P., Velu T., Goldman M. Interleukin-10 differentially regulates B7–1 (CD80) and B7–2 (CD86) expression on human peripheral blood dendritic cells. Eur. J. Immunol. 1995; 25: 2668–2672
   PubMed Web of Science ®Google Scholar
• Malefyt R. D., Yssel H., Devries J. E. Direct effects of IL-10 on subsets of human CD4+ T-cell clones and resting T-cells — specific inhibition of IL-2 production and proliferation. J. Immunol. 1993; 150: 4754–4765
   PubMedGoogle Scholar
• Schandene L., Alonsovega C., Willems F., Gerard C., Delvaux A., Velu T., Devos R., Deboer M., Goldman M. B7/Cd28-dependent IL-5 production by human resting T cells is inhibited by IL-10. J. Immunol. 1994; 152: 4368–4374
   PubMed Web of Science ®Google Scholar
• Chen W. F., Zlotnik A. IL-10 — a novel cytotoxic T-cell differentiation factor. J. Immunol. 1994; 147: 528–534
   Google Scholar
• Tan J. Q., Larsen C. G., Gesser B., Matsushima K., Thestruppedersen K. Human IL-10 is a chemoattractant for CD8+ T-lymphocytes and an inhibitor of IL-8-induced CD4+ T-lymphocyte migration. J. Immunol. 1993; 151: 4545–4551
   PubMedGoogle Scholar
• Carson W. E., Lindemann M. J., Baiocchi R., Linett M., Tan J. C., Chou C. C., Narula S., Caligiuri M. A. The functional characterization of interleukin-10 receptor expression on human natural killer cells. Blood 1995; 85: 3577–3585
   PubMed Web of Science ®Google Scholar
• Go N. F., Castle B. E., Barrett R., Kastelein R., Dang W., Mosmann T. R., Moore K. W., Howard M. Interleukin 10, a novel B cell stimulatory factor: unresponsiveness of X chromosome-linked immunodeficiency B cells. J. Exp. Med. 1990; 172: 1625–1631
   PubMed Web of Science ®Google Scholar
• Defrance T., Vanbervliet B., Briere F., Durand I., Rousset F., Banchereau J. Interleukin-10 and transforming growth factor-beta cooperate to induce anti-Cd40 activated naive human B-cells to secrete immunoglobulin-A. J. Exp. Med. 1992; 175: 671–682
   PubMed Web of Science ®Google Scholar
• Rousset F., Garcia E., Defrance T., Peronne C., Vezzio N., Hsu D. H., Kastelein R., Moore K. W., Banchereau J. Interleukin-10 is a potent growth and differentiation factor for activated human lymphocytes-B. Proc. Natl. Acad. Sci. USA 1992; 89: 1890–1893
   PubMed Web of Science ®Google Scholar
• te Velde A. A., Malefijt R. D., Huijbens R. J.F., Devries J. E., Figdor C. G. IL-10 stimulates monocyte fcgammaR surface expression and cytotoxic activity — distinct regulation of antibody-dependent cellular cytotoxicity by IFN-gamma, IL-4, and IL-10. J. Immunol. 1992; 149: 4048–4052
   PubMedGoogle Scholar
• Akridge R. E., Oyafuso L. K.M., Reed S. G. IL-10 is induced during HIV-1 infection and is capable of decreasing viral replication in human macrophages. J. Immunol. 1994; 153: 5782–5789
   PubMedGoogle Scholar
• Kootstra N. A., Vantwout A. B., Huisman H. G., Miedema F., Schuitemaker H. Interference of interleukin-10 with human immunodeficiency virus type 1 replication in primary monocyte-derived macrophages. J. Virol. 1994; 68: 6967–6975
   PubMedGoogle Scholar
• Masood R., Lunardiiskandar Y., Moudgil T., Zhang Y., Law R. E., Huang C. L., Puri R. K., Levine A. M., Gill P. S. IL-10 inhibits HIV-1 replication and is induced by Tat. Biochem. Biophys. Res. Commun. 1994; 202: 374–383
   PubMed Web of Science ®Google Scholar
• Chang J., Naif H. M., Li S., Jozwiak R., Hoshon M., Cunningham A. L. The inhibition of HIV replication in monocytes by interleukin 10 is linked to inhibition of cell differentiation. AIDS Res. Hum. Retroviruses 1996; 12: 1227–1235
   PubMedGoogle Scholar
• Naif H. M., Chang J., Hoshon M., Li S., Cunningham A. L. Inhibition of human immunodeficiency virus replication in differentiating monocytes by interleukin 10 occurs in parallel with inhibition of cellular RNA expression. AIDS Res. Hum. Retroviruses 1996; 12: 1237–1245
   PubMed Web of Science ®Google Scholar
• Gerard C., Bruyns C., Merchant A., Abramowicz D., Vandenabeele P., Delvaux A., Fiers W., Goldman M., Velu T. Interleukin-10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia. J. Exp. Med. 1993; 177: 547–550
   PubMed Web of Science ®Google Scholar
• Howard M., Muchamuel T., Andrade S., Menon S. Interleukin-10 protects mice from lethal endotoxemia. J. Exp. Med. 1993; 177: 1205–1208
   PubMed Web of Science ®Google Scholar
• Donckier V., Flament V., Gerard C., Abramowicz D., Vandenabeele P., Wissing M., Delvaux A., Fiers W., Leo O., Velu T., et al. Modulation of the release of cytokines and reduction of the shock syndrome induced by anti-CD3 monoclonal antibody in mice by interleukin-10. Transplantation 1994; 57: 1436–1439
   PubMedGoogle Scholar
• Powrie F., Menon S., Coffman R. L. Interleukin-4 and interleukin-10 synergize to inhibit cell-mediated immunity in vivo. Eur. J. Immunol. 1993; 23: 2223–2229
   PubMedGoogle Scholar
• Li L., Elliott J. F., Mosmann T. R. IL-10 inhibits cytokine production, vascular leakage, and swelling during T helper 1 cell-induced delayed-type hypersensitivity. J. Immunol. 1994; 153: 3967–3978
   PubMed Web of Science ®Google Scholar
• Pennline K. J., Roque-Gaffney E., Monahan M. Recombinant human IL-10 prevents the onset of diabetes in the nonobese diabetic mouse. Clin. Immunol. Immunopathol. 1994; 71: 169–175
   PubMedGoogle Scholar
• Rott O., Fleischer B., Cash E. Interleukin-10 prevents experimental allergic encephalomyelitis in rats. Eur. J. Immunol. 1994; 24: 1434–1440
   PubMed Web of Science ®Google Scholar
• Mignongodefroy K., Rott O., Brazillet M. P., Charreire J. Curative and protective effects of IL-10 in experimental autoimmune thyroiditis (EAT) — evidence for IL-10-enhanced cell death in EAT. J. Immunol. 1995; 154: 6634–6643
   PubMedGoogle Scholar
• Wogensen L., Lee M. S., Sarvetnick N. Production of interleukin-10 by islet cells accelerates immune-mediated destruction of beta-cells in nonobese diabetic mice. J. Exp. Med. 1994; 179: 1379–1384
   PubMed Web of Science ®Google Scholar
• Zheng L. M., Ojcius D. M., Garaud F., Roth C., Maxwell E., Li Z., Rong H., Chen J., Wang X. Y., Catino J. J., et al. Interleukin-10 inhibits tumor metastasis through an NK cell-dependent mechanism. J. Exp. Med. 1996; 184: 579–584
   PubMed Web of Science ®Google Scholar
• Vora M., Romero L. I., Karasek M. A. Interleukin-10 induces E-selectin on small and large blood vessel endothelial cells. J. Exp. Med. 1996; 184: 821–829
   PubMedGoogle Scholar
• Taniyama T., Takai S., Miyazaki E., Fukumura R., Sato J., Kobayashi Y., Hirakawa T., Moore K. W., Yamada K. The human interleukin-10 receptor gene maps to chromosome 11q23.3. Hum. Genet. 1995; 95: 99–101
   PubMedGoogle Scholar
• Liu Y., Wei S. H.Y., Ho A. S.Y., Malefyt R. D., Moore K. W. Expression cloning and characterization of a human IL-10 receptor. J. Immunol. 1994; 152: 1821–1829
   PubMed Web of Science ®Google Scholar
• Tan J. C., Braun S., Rong H., Digiacomo R., Dolphin E., Baldwin S., Narula S. K., Zavodny P. J., Chou C. C. Characterization of recombinant extracellular domain of human interleukin-10 receptor. J. Biol. Chem. 1995; 270: 12906–12911
   PubMedGoogle Scholar
• Webernordt R. M., Meraz M. A., Schreiber R. D. Lipopolysaccharide-dependent induction of IL-10 receptor expression on murine fibroblasts. J. Immunol. 1994; 153: 3734–3744
   PubMedGoogle Scholar
• Ho A. S.Y., Liu Y., Khan T. A., Hsu D. H., Bazan J. F., Moore K. W. A receptor for interleukin-10 is related to interferon receptors. Proc. Natl. Acad. Sci. USA 1993; 90: 11267–11271
   PubMed Web of Science ®Google Scholar
• Zdanov A., Schalkhihi C., Gustchina A., Tsang M., Weatherbee J., Wlodawer A. Crystal structure of interleukin-10 reveals the functional dimer with an unexpected topological similarity to interferon gamma. Structure 1995; 3: 591–601
   PubMed Web of Science ®Google Scholar
• Walter M. R., Nagabhushan T. L. Crystal structure of interleukin 10 reveals an interferon gamma-like fold. Biochemistry 1995; 34: 12118–12125
   PubMedGoogle Scholar
• Lamer A. C., David M., Feldman G. M., Igarashi K., Hackett R. H., Webb D. S.A., Sweitzer S. M., Petricoin E. F., Finbloom D. S. Tyrosine phosphorylation of DNA binding proteins by multiple cytokines. Science 1993; 261: 1730–1733
   PubMed Web of Science ®Google Scholar
• Lehmann J., Seegert D., Strehlow I., Schindler C., Lohmannmatthes M. L., Decker T. IL-10-induced factors belonging to the p91 family of proteins bind to IFN-gamma-responsive promoter elements. J. Immunol. 1994; 153: 165–172
   PubMedGoogle Scholar
• Ho A. S.Y., Wei S. H.Y., Mui A. L.F., Miyajima A., Moore K. W. Functional regions of the mouse interleukin-10 receptor cytoplasmic domain. Mol. Cell Biol. 1995; 15: 5043–5053
   PubMed Web of Science ®Google Scholar
• Finbloom D. S., Winestock K. D. IL-10 induces the tyrosine phosphorylation of tyk2 and Jak1 and the differential assembly of STAT1 alpha and STAT3 complexes in human T cells and monocytes. J. Immunol. 1995; 155: 1079–1090
   PubMed Web of Science ®Google Scholar
• Riley J. K., Greenlund A. C., Schreiber R. D. Eur. Cytokine. Netw. 1996; 7: 523, Abstract
   Google Scholar
• Lai C. F., Ripperger J., Morella K. K., Jurlander J., Hawley T. S., Carson W. E., Kordula T., Caliguri M. A., Hawley R. G., Fey G. H., et al. Receptors for interleukin (IL)-10 and IL-6-type cytokines use similar signaling mechanisms for inducing transcription through IL-6 response elements. J., Biol. Chem. 1996; 271: 13968–13975
   PubMed Web of Science ®Google Scholar
• Wang P., Wu P., Siegel M. I., Egan R. W., Billah M. M. IL-10 inhibits transcription of cytokine genes in human peripheral blood mononuclear cells. J. Immunol. 1994; 153: 811–816
   PubMed Web of Science ®Google Scholar
• Wang P., Wu P., Anthes J. C., Siegel M. I., Egan R. W., Billah M. M. Interleukin-10 inhibits interleukin-8 production in human neutrophils. Blood 1994; 83: 2678–2683
   PubMed Web of Science ®Google Scholar
• Romano M. F., Lamberti A., Petrella A., Bisogni R., Tassone P., Formisano S., Venuta S., Turco M. C. IL-10 inhibits nuclear factor-kappa B/Rel nuclear activity in CD3-stimulated human peripheral T lymphocytes. J. Immunol. 1996; 156: 2119–2123
   PubMed Web of Science ®Google Scholar
• Wang P., Wu P., Siegel M. I., Egan R. W., Billah M. M. Interleukin (IL)-10 inhibits nuclear factor kappa B (NF-kB) activation in human monocytes — IL-10 and IL-4 suppress cytokine synthesis by different mechanisms. J. Biol. Chem. 1995; 270: 9558–9563
   PubMed Web of Science ®Google Scholar
• Dokter W. H.A., Koopmans S. B., Vellenga E. Effects of IL-10 and IL-4 on LPS-induced transcription factors (AP-1, NF-IL6 and NF-kB) which are involved in IL-6 regulation. Leukemia 1996; 10: 1308–1316
   PubMedGoogle Scholar
• Yamaoka K., Izuhara K., Otsuka T., Niiro H., Imamura T., Niho Y. Eur. Cytokine. Netw. 1996; 7: 481, Abstract
   Google Scholar
• Geng Y., Gulbins E., Altman A., Lotz M. Monocyte deactivation by interleukin 10 via inhibition of tyrosine kinase activity and the Ras signaling pathway. Proc. Natl. Acad. Sci. USA 1994; 91: 8602–8606
   PubMed Web of Science ®Google Scholar
• Bogdan C., Paik J., Vodovotz Y., Nathan C. Contrasting mechanisms for suppression of macrophage cytokine release by transforming growth factor-beta and interleukin-10. J. Biol. Chem. 1992; 267: 23301–23308
   PubMed Web of Science ®Google Scholar
• Takeshita S., Gage J. R., Kishimoto T., Vredevoe D. L., Martinezmaza O. Differential regulation of IL-6 gene transcription and expression by IL-4 and IL-10 in human monocytic cell lines. J. Immunol. 1996; 156: 2591–2598
   PubMedGoogle Scholar
• Brown C. Y., Lagnado C. A., Vadas M. A., Goodall G. J. Differential regulation of the stability of cytokine mRNAs in lipopolysaccharide-activated blood monocytes in response to interleukin-10. J. Biol. Chem. 1996; 271: 20108–20112
   PubMedGoogle Scholar
• Sieling P. A., Abrams J. S., Yamamura M., Salgame P., Bloom B. R., Rea T. H., Modlin R. L. Immunosuppressive roles for IL-10 and IL-4 in human infection — in vitro modulation of T-cell responses in leprosy. J. Immunol. 1993; 150: 5501–5510
   PubMed Web of Science ®Google Scholar
• Wagner R. D., Czuprynski C. J. Cytokine messenger RNA expression in livers of mice infected with listeria-monocytogenes. J. Leukocyte. Biol. 1993; 53: 525–531
   PubMedGoogle Scholar
• Vecchiarelli A., Retini C., Monari C., Tascini C., Bistoni F., Kozel T. R. Purified capsular polysaccharide of Cryptococcus neoformans induces interleukin-10 secretion by human monocytes. Infect. Immun. 1996; 64: 2846–2849
   PubMedGoogle Scholar
• Borghi P., Fantuzzi L., Varano B., Gessani S., Puddu P., Conti L., Capobianchi M. R., Ameglio F., Belardelli F. Induction of interleukin-10 by human immunodeficiency virus type 1 and its gp120 protein in human monocytes macrophages. J. Virol. 1995; 69: 1284–1287
   PubMedGoogle Scholar
• Takeshita S., Breen E. C., Ivashchenko M., Nishanian P. G., Kishimoto T., Vredevoe D. L., Martinezmaza O. Induction of IL-6 and IL-10 production by recombinant HIV-1 envelope glycoprotein 41 (gp41) in the THP-1 human monocytic cell line. Cell Immunol. 1995; 165: 234–242
   PubMed Web of Science ®Google Scholar
• Mori N., Gill P. S., Mougdil T., Murakami S., Eto S., Prager D. Interleukin-10 gene expression in adult T-cell leukemia. Blood 1996; 88: 1035–1045
   PubMed Web of Science ®Google Scholar
• Goes N., Urmson J., Ramassar V., Halloran P. F. Ischemic acute tubular necrosis induces an extensive local cytokine response — Evidence for induction of interferon-gamma, transforming growth factor-beta 1, granulocyte-macrophage colony-stimulating factor, interleukin-2, and interleukin-10. Transplantation 1995; 59: 565–572
   PubMed Web of Science ®Google Scholar
• Wan S., Marchant A., Desmet J. M., Antoine M., Zhang H. B., Vachiery J. L., Goldman M., Vincent J. L., Leclerc J. L. Human cytokine responses to cardiac transplantation and coronary artery bypass grafting. J. Thorac. Cardiovasc. Surg. 1996; 111: 469–477
   PubMedGoogle Scholar
• Lemoine O., Louis H., Stordeur P., Collet J. M., Goldman M., Deviere J. Critical role of reactive oxygen intermediates in tumor necrosis factor and interleukin-10 production after liver cold ischemia and reperfusion in mice. Gastroenterology 1997; 113, in press
   Google Scholar
• Lemoine O., Marchant A., Durand F., Ickx B., Pradier O., Belghiti J., Abramowicz D., Gelin M., Goldman M., Deviere J. Systemic release of interleukin-10 during orthotopic liver transplantation. Hepatology 1994; 20: 889–892
   PubMedGoogle Scholar
• Lemoine O., Stordeur P., Schandene L., Marchant A., Degroote D., Goldman M., Deviere J. Adenosine enhances IL-10 secretion by human monocytes. J. Immunol. 1996; 156: 4408–4414
   PubMedGoogle Scholar
• Kang K. F., Hammerberg C., Meunier L., Cooper K. D. CD11b(+) macrophages that infiltrate human epidermis after in vivo ultraviolet exposure potently produce IL-10 and represent the major secretory source of epidermal IL-10 protein. J. Immunol. 1994; 153: 5256–5264
   PubMedGoogle Scholar
• Enk C. D., Sredni D., Blauvelt A., Katz S. I. Induction of IL-10 gene expression in human keratinocytes by UVB exposure in vivo and in vitro. J. Immunol. 1995; 154: 4851–4856
   PubMed Web of Science ®Google Scholar
• Goldman M., Merchant A., Schandene L. Endogenous interleukin-10 in inflammatory disorders: regulatory roles and pharmacological modulation. Ann. NY Acad. Sci. 1996; 796: 282–293
   PubMedGoogle Scholar
• Platzer C., Volk H. D., Platzer M. 5′ Noncoding sequence of human IL-10 gene obtained by oligo-cassette PCR walking. DNA Sequence 1994; 4: 399–401
   PubMed Web of Science ®Google Scholar
• Kube D., Platzer C., Vonknethen A., Straub H., Bohlen H., Hafner M., Tesch H. Isolation of the human interleukin 10 promoter. Characterization of the promoter activity in Burkitt's lymphoma cell lines. Cytokine 1995; 7: 1–7
   PubMed Web of Science ®Google Scholar
• Martinez C., Delgado M., Gomariz R. P., Ganea D. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide-38 inhibit IL-10 production in murine T lymphocytes. J. Immunol. 1996; 156: 4128–4136
   PubMedGoogle Scholar
• Tomkins P. T., Cooper K. L., Appleby P., Webber D. G. Effect of pharmacological agents on the production of interleukin-10 by the murine D10.G4.1 T(H)2 cell line in vitro. Int. J. Immunopharmacol. 1995; 17: 619–625
   PubMedGoogle Scholar
• Baeuerle P. A., Henkel T. Function and activation of NF-kB in the immune system. Annu. Rev. Immunol. 1994; 12: 141–179
   PubMed Web of Science ®Google Scholar
• Navikas V., Link J., Persson C., Olsson T., Hojeberg B., Ljungdahl A., Link H., Wahren B. Increased mRNA expression of IL-6, IL-10, TNF-alpha, and perforin in blood mononuclear cells in human HIV infection. J. Acq. Immun. Defic. Synd. Hum. R. 1995; 9: 484–489
   PubMedGoogle Scholar
• Scala G., Quinto I., Ruocco M. R., Mallardo M., Ambrosino C., Squitieri B., Tassone P., Venuta S. Epstein-Barr virus nuclear antigen 2 transactivates the long terminal repeat of human immunodeficiency virus type 1. J. Virol. 1993; 67: 2853–2861
   PubMedGoogle Scholar
• Hammarskjld M., Simurda M. C. Epstein-Barr virus latent membrane protein transactivates the human immunodeficiency virus type 1 long terminal repeat through induction of NF-kB activity. J. Virol. 1992; 66: 6496–6501
   PubMedGoogle Scholar
• Wanidworanun C., Strober W. Predominant role of tumor necrosis factor-alpha in human monocyte IL-10 synthesis. J. Immunol. 1993; 151: 6853–6861
   PubMed Web of Science ®Google Scholar
• Platzer C., Meisel C., Vogt K., Platzer M., Volk H. D. Up-regulation of monocytic IL-10 by tumor necrosis factor-alpha and cAMP elevating drugs. Int. Immunol. 1995; 7: 517–523
   PubMed Web of Science ®Google Scholar
• Eskdale J., Gallagher G. A polymorphic dinucleotide repeat in the human IL-10 promoter. Immunogenetics 1995; 42: 444–445
   PubMedGoogle Scholar
• Diazmitoma F., Kumar A., Karimi S., Kryworuchko M., Daftarian M. P., Creery W. D., Filion L. G., Cameron W. Expression of IL-10, IL-4 and interferon-gamma in unstimulated and mitogen-stimulated peripheral blood lymphocytes from HIV-seropositive patients. Clin. Exp. Immunol. 1995; 102: 31–39
   PubMedGoogle Scholar
• Akashi M., Shaw G., Gross M., Saito M., Koeffler P. Role of AUUU sequences in stabilization of granulocyte-macrophage colony-stimulating factor RNA in stimulated cells. Blood 1991; 78: 2005–2012
   PubMed Web of Science ®Google Scholar
• Shaw G., Kamen R. A conserved AU sequence from the 3 untranslated region of GM-CSF mRNA mediates selective mRNA degradation. Cell 1986; 46: 659–667
   PubMed Web of Science ®Google Scholar
• Stordeur P., Schandene L., Durez P., Gerard C., Goldman M., Velu T. Spontaneous and cycloheximide-induced interleukin-10 mRNA expression in human mononuclear cells. Mol. Immunol. 1995; 32: 233–239
   PubMedGoogle Scholar
• Marchant A., Amraoui Z., Gueydan C., Bruyns C., Lemoine O., Vandenabeele P., Fiers W., Buurman W. A., Goldman M. Methylprednisolone differentially regulates IL-10 and tumour necrosis factor (TNF) production during murine endotoxaemia. Clin. Exp. Immunol. 1996; 106: 91–96
   PubMedGoogle Scholar
• Vanderpoll T., Coyle S. M., Barbosa K., Braxton C. C., Lowry S. F. Epinephrine inhibits tumor necrosis factor-alpha and potentiates interleukin 10 production during human endotoxemia. J. Clin. Invest. 1996; 97: 713–719
   PubMedGoogle Scholar
• Bhardwaj R. S., Schwarz A., Becher E., Mahnke K., Aragane Y., Schwarz T., Luger T. A. Pro-opiomelanocortin-derived peptides induce IL-10 production in human monocytes. J. Immunol. 1996; 156: 2517–2521
   PubMed Web of Science ®Google Scholar
• Daftarian P. M., Kumar A., Kryworuchko M., Diazmitoma F. IL-10 production is enhanced in human T cells by IL-12 and IL-6 and in monocytes by tumor necrosis factor-alpha. J. Immunol. 1996; 157: 12–20
   PubMed Web of Science ®Google Scholar
• Tilg H., Atkins M. B., Dinarello C. A., Mier J. W. Induction of circulating interleukin 10 by interleukin 1 and interleukin 2, but not interleukin 6 immunotherapy. Cytokine 1995; 7: 734–739
   PubMed Web of Science ®Google Scholar
• Meyaard L., Hovenkamp E., Otto S. A., Miedema F. IL-12-induced IL-10 production by human T cells as a negative feedback for IL-12-induced immune responses. J. Immunol. 1996; 156: 2776–2782
   PubMed Web of Science ®Google Scholar
• Jeannin P., Delneste Y., Seveso M., Life P., Bonnefoy J. Y. IL-12 synergizes with IL-2 and other stimuli in inducing IL-10 production by human T cells. J. Immunol. 1996; 156: 3159–3165
   PubMed Web of Science ®Google Scholar
• Mingari M. C., Maggi E., Cambiaggi A., Annunziato F., Schiavetti F., Manetti R., Moretta L., Romagnani S. Development in vitro of human CD4(+) thymocytes into functionally mature Th2 cells. Exogenous interleukin-12 is required for priming thymocytes to produce both Th1 cytokines and interleukin-10. Eur. J. Immunol. 1996; 26: 1083–1087
   PubMed Web of Science ®Google Scholar
• Schandene L., Delprete G. F., Cogan E., Stordeur P., Crusiaux A., Kennes B., Romagnani S., Goldman M. Recombinant interferon-alpha selectively inhibits the production interleukin-5 by human CD4(+) T cells. J. Clin. Invest. 1996; 97: 309–315
   PubMed Web of Science ®Google Scholar
• Aman M. J., Tretter T., Eisenbeis I., Bug G., Decker T., Aulitzky W. E., Tilg H., Huber C., Peschel C. Interferon-alpha stimulates production of interleukin-10 in activated CD4(+) T cells and monocytes. Blood 1996; 87: 4731–4736
   PubMed Web of Science ®Google Scholar
• Rep M. H.G., Hintzen R. Q., Polman C. H., Vanlier R. A.W. Recombinant interferon-beta blocks proliferation but enhances interleukin-10 secretion by activated human T-cells. J. Neuroimmunol. 1996; 67: 111–118
   PubMed Web of Science ®Google Scholar
• Maeda H., Kuwahara H., Ichimura Y., Ohtsuki M., Kurakata S., Shiraishi A. TGF-beta enhances macrophage ability to produce IL-10 in normal and tumor-bearing mice. J. Immunol. 1995; 155: 4926–4932
   PubMed Web of Science ®Google Scholar
• Strassmann G., Patilkoota V., Finkelman F., Fong M., Kambayashi T. Evidence for the involvement of interleukin 10 in the differential deactivation of murine peritoneal macrophages by prostaglandin E(2). J. Exp. Med. 1994; 180: 2365–2370
   PubMed Web of Science ®Google Scholar
• Jilg S., Barsig J., Leist M., Kusters S., Volk H. D., Wendel A. Enhanced release of interleukin-10 and soluble tumor necrosis factor receptors as novel principles of methylxanthine action in murine models of endotoxic shock. J. Pharmacol. Exp. Ther. 1996; 278: 421–431
   PubMedGoogle Scholar
• Kambayashi T., Jacob C. O., Zhou D., Mazurek N., Fong M., Strassmann G. Cyclic nucleotide phosphodiesterase type IV participates in the regulation of IL-10 and in the subsequent inhibition of TNF-alpha and IL-6 release by endotoxin-stimulated macrophages. J. Immunol. 1995; 155: 4909–4916
   PubMed Web of Science ®Google Scholar
• Durez P., Abramowicz D., Gerard C., Vanmechelen M., Amraoui Z., Dubois C., Leo O., Velu T., Goldman M. In vivo induction of interleukin-10 by anti-CD3 monoclonal antibody or bacterial lipopolysaccharide — differential modulation by cyclosporin-A. J. Exp. Med. 1993; 177: 551–555
   PubMed Web of Science ®Google Scholar
• Bourrie B., Bouaboula M., Benoit J. M., Derocq J. M., Esclangon M., Lefur G., Casellas P. Enhancement of endotoxin-induced interleukin-10 production by SR 31747A, a sigma ligand. Eur. J. Immunol. 1995; 25: 2882–2887
   PubMedGoogle Scholar
• Bourrie B., Benoit J. M., Derocq J. M., Esclangon M., Thomas C., Lefur G., Casellas P. A sigma ligand, SR 31747A, potently modulates staphylococcal enterotoxin B-induced cytokine production in mice. Immunology 1996; 88: 389–393
   PubMedGoogle Scholar
• Mengozzi M., Fantuzzi G., Faggioni R., Marchant A., Goldman M., Orencole S., Clark B. D., Sironi M., Benigni F., Ghezzi P. Chlorpromazine specifically inhibits peripheral and brain TNF production, and up-regulates IL-10 production, in mice. Immunology 1994; 82: 207–210
   PubMedGoogle Scholar
• Tarazona R., Gonzalezgarcia A., Zamzami N., Marchetti P., Frechin N., Gonzalo J. A., Ruizgayo M., Vanrooijen N., Martineza C., Kroemer G. Chlorpromazine amplifies macrophage-dependent IL-10 production in vivo. J. Immunol. 1995; 154: 861–870
   PubMedGoogle Scholar
• Ianaro A., Odonnell C. A., Dirosa M., Liew F. Y. A nitric oxide synthase inhibitor reduces inflammation, down-regulates inflammatory cytokines and enhances interleukin-10 production in carrageenin-induced oedema in mice. Immunology 1994; 82: 370–375
   PubMed Web of Science ®Google Scholar
• Napolitano L. M., Campbell C. Nitric oxide inhibition normalizes splenocyte interleukin-10 synthesis in murine thermal injury. Arch. Surg. 1994; 129: 1276–1283
   PubMedGoogle Scholar
• Turner D. M., Williams D. M., Sankaran D., Lazarus M., Sinnott P. J., Hutchinson I. V. An investigation of polymorphism in the interleukin-10 gene promoter. Eur. J. Immunogenet. 1997; 24: 1–8
   PubMedGoogle Scholar
• Eskdale J., Wordsworth P., Bowman S., Field M., Gallagher G. Association between polymorphisms at the human IL-10 locus and systemic lupus erythematosus. Tissue Antigens 1997; 49: 635–639
   PubMed Web of Science ®Google Scholar
• Eskdale J., Kube D., Tesch H., Gallagher G. Mapping of the human IL10 gene and further characterization of the 5′ flanking sequence. Immunogenetics 1997; 46: 120–128
   PubMed Web of Science ®Google Scholar